Variant report

Variant	rs372654587
Chromosome Location	chr2:182542773-182542774
allele	C/G
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr2:182541170..182543258-chr2:182550470..182553269,2	MCF-7	breast:
2	chr2:182542601..182545361-chr2:182546496..182548838,2	MCF-7	breast:

Variant related genes	Relation type
ENSG00000234595	Chromatin interaction

Extended variants
information (count: 6 )
Associated
traits (count: 0)

Variant overlapped rSNPs/rCNVs (count:6 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv1005870	chr2:181968637-182921439	Enhancers Strong transcription Weak transcription Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Genic enhancers ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	39 gene(s)	inside rSNPs	diseases
2	nsv536063	chr2:181968637-182921439	Enhancers Active TSS Weak transcription Strong transcription Bivalent/Poised TSS Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	39 gene(s)	inside rSNPs	diseases
3	nsv1014910	chr2:182375267-182544114	Active TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription Bivalent/Poised TSS Strong transcription Bivalent Enhancer Genic enhancers ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	7 gene(s)	inside rSNPs	diseases
4	nsv536065	chr2:182375267-182544114	Enhancers Active TSS Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh Strong transcription Bivalent/Poised TSS Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	7 gene(s)	inside rSNPs	diseases
5	nsv834477	chr2:182438121-182593527	Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers ZNF genes & repeats Bivalent/Poised TSS Flanking Active TSS Active TSS Weak transcription Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	9 gene(s)	inside rSNPs	diseases
6	nsv820203	chr2:182542727-182543097	Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS	TF binding region CpG island Chromatin interactive region	1 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:56 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:182542200-182543800	Bivalent Enhancer	ES-UCSF4 Cell Line	embryonic stem cell
2	chr2:182542400-182542800	Bivalent Enhancer	H9 Cell Line	embryonic stem cell
3	chr2:182542400-182542800	Flanking Bivalent TSS/Enh	HUES48 Cell Line	embryonic stem cell
4	chr2:182542400-182542800	Bivalent Enhancer	Primary neutrophils fromperipheralblood	blood
5	chr2:182542400-182542800	Bivalent Enhancer	Primary hematopoietic stem cells short term culture	blood
6	chr2:182542400-182542800	Bivalent Enhancer	Primary T killer naive cells fromperipheralblood	blood
7	chr2:182542400-182542800	Flanking Bivalent TSS/Enh	Fetal Intestine Large	intestine
8	chr2:182542400-182542800	Bivalent Enhancer	Lung	lung
9	chr2:182542400-182542800	Enhancers	Spleen	Spleen
10	chr2:182542400-182543200	Flanking Bivalent TSS/Enh	H9 Derived Neuron Cultured Cells	ES cell derived
11	chr2:182542400-182543200	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
12	chr2:182542400-182543200	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
13	chr2:182542400-182543400	Bivalent Enhancer	ES-I3 Cell Line	embryonic stem cell
14	chr2:182542400-182543400	Bivalent Enhancer	iPS DF 19.11 Cell Line	embryonic stem cell
15	chr2:182542400-182543400	Bivalent/Poised TSS	Primary T cells from cord blood	blood
16	chr2:182542400-182543400	Bivalent/Poised TSS	Brain Dorsolateral Prefrontal Cortex	brain
17	chr2:182542400-182543600	Bivalent Enhancer	H1 Derived Mesenchymal Stem Cells	ES cell derived
18	chr2:182542400-182543600	Transcr. at gene 5' and 3'	Pancreatic Islets	Pancreatic Islet
19	chr2:182542400-182543600	Bivalent Enhancer	Fetal Muscle Trunk	muscle
20	chr2:182542400-182545000	Bivalent Enhancer	Ganglion Eminence derived primary cultured neurospheres	brain
21	chr2:182542400-182545400	Bivalent/Poised TSS	Brain Hippocampus Middle	brain
22	chr2:182542400-182546200	Bivalent/Poised TSS	Brain Inferior Temporal Lobe	brain
23	chr2:182542600-182542800	Flanking Bivalent TSS/Enh	H1 Cell Line	embryonic stem cell
24	chr2:182542600-182542800	Bivalent Enhancer	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
25	chr2:182542600-182542800	Bivalent Enhancer	IMR90 fetal lung fibroblasts Cell Line	lung
26	chr2:182542600-182542800	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
27	chr2:182542600-182542800	Flanking Bivalent TSS/Enh	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
28	chr2:182542600-182542800	Flanking Bivalent TSS/Enh	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
29	chr2:182542600-182542800	Bivalent Enhancer	Primary Natural Killer cells fromperipheralblood	blood
30	chr2:182542600-182542800	Bivalent/Poised TSS	Primary T killer memory cells from peripheral blood	blood
31	chr2:182542600-182542800	Flanking Bivalent TSS/Enh	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
32	chr2:182542600-182542800	Bivalent Enhancer	Muscle Satellite Cultured Cells	--
33	chr2:182542600-182542800	Flanking Bivalent TSS/Enh	Foreskin Fibroblast Primary Cells skin01	Skin
34	chr2:182542600-182542800	Flanking Bivalent TSS/Enh	Adipose Nuclei	Adipose
35	chr2:182542600-182542800	Flanking Bivalent TSS/Enh	Liver	Liver
36	chr2:182542600-182542800	Bivalent Enhancer	Esophagus	oesophagus
37	chr2:182542600-182542800	Bivalent Enhancer	Fetal Muscle Leg	muscle
38	chr2:182542600-182542800	Bivalent Enhancer	Left Ventricle	heart
39	chr2:182542600-182542800	Bivalent Enhancer	Right Ventricle	heart
40	chr2:182542600-182542800	Bivalent Enhancer	Small Intestine	intestine
41	chr2:182542600-182542800	Flanking Bivalent TSS/Enh	A549	lung
42	chr2:182542600-182542800	Bivalent Enhancer	Monocytes-CD14+_RO01746	blood
43	chr2:182542600-182542800	Bivalent Enhancer	NHDF-Ad	bronchial
44	chr2:182542600-182543000	Bivalent Enhancer	Fetal Brain Male	brain
45	chr2:182542600-182543000	Flanking Bivalent TSS/Enh	Fetal Brain Female	brain
46	chr2:182542600-182543000	Flanking Active TSS	Pancreas	Pancrea
47	chr2:182542600-182543200	Bivalent Enhancer	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
48	chr2:182542600-182543200	Bivalent Enhancer	iPS DF 6.9 Cell Line	embryonic stem cell
49	chr2:182542600-182543200	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin03	Skin
50	chr2:182542600-182543200	Bivalent Enhancer	Fetal Intestine Small	intestine

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links